BAHAR SUMBUL-YUKSEL

Allopathic & Osteopathic Physicians|Internal Medicine|Rheumatology ORLANDO, FL NPI 1013903327

General Payments — all program years on this page

$1,426.12

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 85
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $381.83 across 15 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $381.8315

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
Amgen Inc. $97.674
UCB, Inc. $80.173
Aurinia Pharma U.S., Inc. $47.492
GENZYME CORPORATION $32.781
Sandoz Inc. $31.621
E.R. Squibb & Sons, L.L.C. $30.041
Acerta Pharma LLC $25.041
ABBVIE INC. $22.141
PFIZER INC. $14.881

By program year

Program yearAmountRecords
2018 $1,022.2369
2019 $22.061
2024 $381.8315

Records — PY2024 (15)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1089365681 Sandoz Inc. $31.62 12/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1101808126 E.R. Squibb & Sons, L.L.C. $30.04 12/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105575342 AstraZeneca Pharmaceuticals LP $25.04 11/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1106181765 ABBVIE INC. $22.14 11/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1111718723 Amgen Inc. $16.74 02/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1111718725 Amgen Inc. $28.69 11/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117394006 Amgen Inc. $29.41 11/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117695403 Amgen Inc. $22.83 12/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131505205 PFIZER INC. $14.88 10/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139706223 GENZYME CORPORATION $32.78 12/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1143121158 UCB, Inc. $24.08 12/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1143130996 UCB, Inc. $32.16 11/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1143131001 UCB, Inc. $23.93 12/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1150692933 Aurinia Pharma U.S., Inc. $23.25 11/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1150692935 Aurinia Pharma U.S., Inc. $24.24 12/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.